Medical therapy for secondary prevention of stroke

被引:1
|
作者
Regesta, G [1 ]
机构
[1] Osped San Martino Genova, Dept Neurol, Stroke Unit, I-16132 Genoa, Italy
关键词
D O I
10.1081/CEH-120015332
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The identification and modification of risk factors for stroke and their appropriate management can lead to reduction of stroke incidence. The real impact on recurrences of risk factors associated with lifestyles has not been thoroughly investigated, and the possible role of their modification in secondary prevention is principally extrapolated from primary prevention studies. On the other hand, several pathological conditions such as hypertension, atria] fibrillation, carotid stenosis, and diabetes are known to favour the risk of recurrence. Available antiplatelet regimens offer only partial protection against stroke and more efficacious antithrombotic agents would be useful. There is no doubt that warfarin is effective in preventing recurrence in stroke patients with atrial fibrillation. However, a careful etiological subtyping of stroke is recommended before starting treatment.
引用
收藏
页码:555 / 562
页数:8
相关论文
共 50 条
  • [1] Secondary stroke prevention and antiplatelet therapy
    Horton, HL
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (12) : 2567 - 2568
  • [2] Antiplatelet therapy for secondary stroke prevention
    Forbes, CD
    [J]. SCOTTISH MEDICAL JOURNAL, 1999, 44 (02) : 54 - 59
  • [3] Antiplatelet therapy in secondary stroke prevention
    Worrall B.B.
    Johnston K.C.
    [J]. Current Atherosclerosis Reports, 2000, 2 (2) : 104 - 109
  • [4] Antiplatelet Therapy in the Secondary Prevention of Stroke
    Graeme J. Hankey
    [J]. 中国循证医学杂志, 2004, (03) : 150 - 156
  • [5] Antithrombotic therapy in the secondary prevention of stroke
    Melnikova, E. V.
    Kadinskaya, M. I.
    Gerasimenko, D. V.
    Shmonin, A. A.
    [J]. ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2010, 110 (12) : 23 - 27
  • [6] Improved medical treatment in secondary prevention of stroke
    Rothwell, Peter M.
    Markus, Hugh S.
    [J]. LANCET, 2014, 383 (9914): : 290 - 291
  • [7] Secondary stroke prevention—personalized antiplatelet therapy
    David Tanne
    [J]. Nature Reviews Neurology, 2012, 8 : 536 - 537
  • [8] Antiplatelet Therapy for Secondary Prevention of Ischemic Stroke
    Pace, Wilson D.
    Earl, Ali
    Bryant, Casey
    Hansen, Cory
    [J]. US PHARMACIST, 2020, 45 (01) : HS8 - HS12
  • [9] Antiplatelet therapy in secondary ischemic stroke prevention
    Horner, S
    Schmidbauer, M
    Schnaberth, G
    Weiss, S
    Niederkorn, K
    Schmidt, R
    Homann, CN
    Ott, E
    Hartung, HP
    [J]. NEUROPSYCHIATRIE, 2000, 14 (01) : 12 - 22
  • [10] Antiaggregation therapy is a secondary prevention of ischemic stroke
    Kamchatnov, P. R.
    Chugunov, A. V.
    Umarova, Kh. Ya.
    [J]. ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2008, : 58 - 64